Table 1 Patient characteristics, pregnancy outcome parameters, and differences among women who received tocolytic therapy as recommended in the guidelines (EVB) and women who received tocolytic therapy tocolysis in contrast with these recommendations (nonEVB)
Total | EVB | nonEVB | p EVB vs nonEVB | |
|---|---|---|---|---|
Women (n) | 309 | 93 | 198 | |
Characteristics | ||||
Maternal Age | 30.78 ± 5.8 | 30.35 ± 6.0 | 30.93 ± 5.6 | 0.699a |
Maternal BMI | 23.25 ± 4.7 | 23.25 ± 4.6 | 23.17 ± 4.8 | 0.676a |
Smoking in pregnancy | 37 (12.0%) | 14 (15.1%) | 21 (10.6%) | 0.371 b |
ART | 58 (18.7%) | 12 (12.9%) | 34 (17.2%) | 0.470b |
Parity | 0.64 ± 0.9 | 0.72 ± 1.0 | 0.62 ± 0.9 | 0.372 a |
Multiple pregancy | 85 (27.5%) | 18 (19.4%) | 57 (28.8%) | 0.116b |
GA at 1st TL (weeks) | 28 (25–31) | 30 (27–32) | 27 (24–30) | < 0.001a |
Children (n) | 395 | 111 | 265 | |
Pregnancy Outcome | ||||
GA at delivery (weeks) | 35 (31–38) | 38 (35–39) | 34 (30–38) | < 0.001a |
< 28 + 0 | 31 (10.0%) | 4 (4.3%) | 23 (11.6%) | < 0.001a |
28 + 0–33 + 6 | 83 (26.9%) | 10 (10.8%) | 64 (32.3%) | |
> 34 + 0 | 195 (63.1%) | 79 (84.9%) | 111 (56.1%) | |
Birth weight (g) | ||||
< 1000 | 33 (8.4%) | 2 (1.8%) | 29 (11.1%) | < 0.001a |
1000–2000 | 117 (29.9%) | 20 (18.2%) | 82 (31.4%) | |
> 2000 | 242 (61.7%) | 88 (80%) | 150 (57.5%) | |
UApH | 7.3 ± 0.2 | 7.29 ± 0.1 | 7.31 ± 0.2 | 0.562a |
Transfer ad NICU | 203 (51.4%) | 35 (31.5%) | 153 (57.8%) | < 0.001b |